Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer

Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer

Triple negative breast cancer (TNBC) is the most aggressive breast cancer accounting for around 15% of identified breast cancer cases. TNBC lacks human epidermal growth factor receptor 2 (HER2) amplification, is hormone independent estrogen (ER) and progesterone receptors (PR) negative, and is not r...

Full description

Bibliographic Details
Main Authors: Fatemah Bahman, Valeria Pittalà, Mohamed Haider, Khaled Greish
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Personalized Medicine
Subjects:
TNBC
dasatinib
poly(styrene-co-maleic acid) micelles
nanoformulation
metabolism
EPR
Online Access:https://www.mdpi.com/2075-4426/11/6/559

Internet

https://www.mdpi.com/2075-4426/11/6/559

Similar Items